455 related articles for article (PubMed ID: 1846761)
21. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
22. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the thrombin-platelet reactions by DuP 714.
Chiu AT; Mousa SA; Pease LJ; Roscoe WA; Bozarth JM; Reilly TM; Smith RD; Timmermans PB
Biochem Biophys Res Commun; 1991 Sep; 179(3):1500-8. PubMed ID: 1930190
[TBL] [Abstract][Full Text] [Related]
24. Platelet shape change and Ca2+ mobilization induced by collagen, but not thrombin or ADP, are inhibited by phenylarsine oxide.
Greenwalt DE; Tandon NN
Br J Haematol; 1994 Dec; 88(4):830-8. PubMed ID: 7819106
[TBL] [Abstract][Full Text] [Related]
25. Ni2+ impairs thrombin-induced signal transduction by acting on the agonist and/or receptor in human platelets.
Azula FJ; Alonso R; Marino A; Trueba M; Macarulla JM
Am J Physiol; 1993 Dec; 265(6 Pt 1):C1681-8. PubMed ID: 8279529
[TBL] [Abstract][Full Text] [Related]
26. Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets.
Palés J; Palacios-Araus L; López A; Gual A
Biochim Biophys Acta; 1991 May; 1064(2):169-74. PubMed ID: 1645196
[TBL] [Abstract][Full Text] [Related]
27. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of intracellular histamine in platelets is associated with activation of protein kinase C, but not with mobilization of Ca2+.
Saxena SP; Robertson C; Becker AB; Gerrard JM
Biochem J; 1991 Jan; 273(Pt 2)(Pt 2):405-8. PubMed ID: 1899334
[TBL] [Abstract][Full Text] [Related]
29. Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.
Martinson EA; Scheible S; Greinacher A; Presek P
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):623-8. PubMed ID: 7544577
[TBL] [Abstract][Full Text] [Related]
30. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of action of two new pyrimidoquinoline and isoquinoline derivatives in human platelets.
Leoncini G; Signorello MG; Grossi GC; Di Braccio M
Thromb Res; 1997 Sep; 87(5):483-92. PubMed ID: 9306622
[TBL] [Abstract][Full Text] [Related]
32. Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets.
Srivastava KC; Malhotra N
Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):73-81. PubMed ID: 2011614
[TBL] [Abstract][Full Text] [Related]
33. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
Vuorinen P; Laustiola KE
Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
[TBL] [Abstract][Full Text] [Related]
34. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
35. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules.
van Willigen G; Gorter G; Akkerman JW
Arterioscler Thromb; 1994 Jan; 14(1):41-6. PubMed ID: 8274476
[TBL] [Abstract][Full Text] [Related]
36. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
[TBL] [Abstract][Full Text] [Related]
37. Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production.
Anfossi G; Trovati M; Mularoni E; Massucco P; Cavalot F; Mattiello L; Emanuelli G
Arch Int Pharmacodyn Ther; 1990; 307():142-61. PubMed ID: 1982777
[TBL] [Abstract][Full Text] [Related]
38. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
39. Effect of anethole dithiolthione on human platelet aggregation.
Selley ML; McGuiness JA; Bartlett MR; Ardlie NG
Arzneimittelforschung; 1992 Mar; 42(3):318-21. PubMed ID: 1497692
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
Matsueda R; Umeyama H; Puri RN; Bradford HN; Colman RW
Pept Res; 1994; 7(1):32-5. PubMed ID: 8019060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
